UCOPE – “Clinical Urine Expanded Opioid Confirm”

Update to specimen information, stability, methodology, and reference range.

Specimen Information:

• This test is for clinical use only and not intended for employment related testing.
• This panel is designed to detect pain drugs including buprenorphine, fentanyl, meperidine, oxycodone, and tramadol in urine. See Reference Range for a complete list of analytes included.
• Quantitative results are reported.
• Alternative ordering options:
  • Qualitative pain management panel with screen only, PN03A
  • Quantitative pain management panel with reflex to confirmation, PN03C

Stability: Room temperature: 48 hours
Refrigerated: 14 days
Frozen: 30 days 

Methodology: Liquid Chromatography/Tandem Mass Spectrometry 

Reference Range:

Confirmation decision level:
Fentanyl: 1 ng/mL
Norfentanyl: 1 ng/mL
Buprenorphine: 5 ng/mL
Naloxone: 5 ng/mL
Norbuprenorphine: 5 ng/mL
O-desmethyltramadol: 5 ng/mL
Tramadol: 5 ng/mL
Codeine: 25 ng/mL
Morphine: 25 ng/mL
Hydrocodone: 25 ng/mL
Hydromorphone: 25 ng/mL
Oxycodone: 25 ng/mL
Oxymorphone: 25 ng/mL